Bruker Q2 Revenue Jumps 10 Percent as Profit Surges 69 Percent; Shares Climb 6 Percent | GenomeWeb
NEW YORK (GenomeWeb News) – Bruker Biosciences today reported that total revenues for the second quarter increased nearly 10 percent as net income jumped 69 percent.
The report caused shares in Bruker to trade up 6 percent, or $.35, at $5.86 in mid-afternoon trading.
Receipts for the three months ended June 30 increased to $78 million from $71 million year over year.
R&D costs declined 3 percent to $10.6 million from $11 million from the comparable quarter a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.